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According to current dogma, there is little or no ongoing neuro-
genesis in the fully developed adult enteric nervous system. This lack
of neurogenesis leaves unanswered the question of how enteric
neuronal populations are maintained in adult guts, given previous
reports of ongoing neuronal death. Here, we confirm that despite
ongoing neuronal cell loss because of apoptosis in the myenteric
ganglia of the adult small intestine, total myenteric neuronal num-
bers remain constant. This observed neuronal homeostasis is main-
tained by new neurons formed in vivo from dividing precursor cells
that are located within myenteric ganglia and express both Nestin
and p75NTR, but not the pan-glial marker Sox10. Mutation of the
phosphatase and tensin homolog gene in this pool of adult precur-
sors leads to an increase in enteric neuronal number, resulting in
ganglioneuromatosis, modeling the corresponding disorder in hu-
mans. Taken together, our results show significant turnover and
neurogenesis of adult enteric neurons and provide a paradigm for
understanding the enteric nervous system in health and disease.
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The enteric nervous system (ENS) controls or regulates vitalgastrointestinal functions, including motility, secretion, local
immunity, and inflammation, and represents the largest collection
of autonomous neurons outside of the brain (1). Disorders in-
volving the ENS are common and major contributors to the health
burden throughout the world (2). Although the ENS is constantly
exposed to mechanical stress (3), as well as potential environ-
mental threats from luminal contents (4), it is not known how the
numbers of enteric neurons in the healthy adult small intestine
remain remarkably constant for most of adult life (5). Although
continuous production of new neurons in the gut would appear to
be needed to offset the observed apoptosis-mediated neuronal loss
(6), such neurogenesis has been remarkably difficult to demon-
strate and in vivo enteric neurogenesis in adults remains highly
controversial (7–10). A second and related conundrum in this
field has been the inability to confidently determine if a true
enteric neural precursor cell (ENPC) exists in the gut, despite
ample demonstration of stem-cell like behavior (self-renewal and
multipotency) in vitro of cells isolated from embryonic and adult
intestine using a variety of markers (7–9, 11–23). In this study, we
have resolved these controversies by successfully identifying the
ENPC capable of rapid neurogenesis in vivo to keep up with what
we show to be a high rate of ongoing neuronal apoptosis in the adult
small intestine. Furthermore, unchecked proliferation of these
precursor cells leads to an intestinal phenotype that resembles hu-
man ganglioneuromatosis, a disorder of intestinal dysmotility seen
in patients (24). Our results indicate a remarkable rate of turnover
of adult neurons in the small intestine and provide a unique para-
digm for understanding the ENS in health and disease.
Results
Significant Neuronal Loss Occurs in the ENS in the Healthy Adult Gut.
We determined if enteric neurons are dying at a significant rate
in healthy adults, thus establishing the need for replacement by
neurogenesis. First, we stained adult murine myenteric ganglia
with a cleaved caspase-3–specific antibody that has previously
been shown to mark neurons from the central and ENS that
are fated for apoptosis (25, 26). We found that a significant
Significance
The demonstration of a robust neurogenesis program in the adult
gut and the existence of an enteric neural precursor cell (ENPC)
responsible for the same has profound biological and clinical im-
plications. This demonstrates the presence of robust adult neuro-
genesis outside of the CNS, and indicates the vulnerability of the
enteric nervous system to exogenous influences, even in adults. As
an example, it is possible that acquired diseases of the enteric
nervous system, such as achalasia, may result from a loss of ENPC,
analogous to congenital disorders, such as Hirschsprung’s. The
ability to identify the adult ENPC will therefore enable a new un-
derstanding of the pathogenesis of enteric neuromuscular diseases
as well as the development of novel regenerative therapies.
Author contributions: S.K., M.-A.M., H.S., M.B., and P.J.P. designed research; S.K., J.L., C.S.,
S.-C.T., Y.-Y.F., L.L., Q.L., M.S., C.L., L.B., N.R., M.A., M.B., and P.J.P. performed research;
S.K., C.S., S.-C.T., M.S., G.E., N.R., M.A., X.S., X.D., M.J.B., E.M.S.-S., and P.J.P. contributed
new reagents/analytic tools; S.K., M.-A.M., J.L., C.S., R.P.K., M.B., and P.J.P. analyzed data;
and S.K., M.-A.M., and P.J.P. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
1To whom correspondence should be addressed. Email: ppasric1@jhmi.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1619406114/-/DCSupplemental.
www.pnas.org/cgi/doi/10.1073/pnas.1619406114 PNAS | Published online April 18, 2017 | E3709–E3718
N
EU
RO
SC
IE
N
CE
PN
A
S
PL
U
S
number (mean ± SE of percent cleaved caspase-3+ neurons per
ganglia = 11.49 ± 0.50, total numbers of ganglia counted = 48, from 3
adult mice) of myenteric neurons express the enzyme cleaved caspase-
3 (Fig. 1A). The presence of significant levels of apoptotic neurons by
this method in the young adult myenteric plexus was recently con-
firmed in an independent publication (27). Biochemical proof of the
enzymatic activity of caspase-3 was then obtained using a fluorescently
labeled caspase-3/7 substrate (Fig. 1C) (28), accompanied by in vivo
labeling of myenteric neurons with propidium iodide (PI), which is
indicative of dying cells (Fig. 1B and Fig. S1 A and B) (29–31).
Further proof of the limited longevity of adult enteric neurons
was obtained using a nitric oxide synthase 1 (NOS1)-creERT2
mouse, which we have previously reported (32). This mouse was
bred with a mouse containing a floxed tdTomato gene and the
resulting NOS1-creERT2:tdTomato progeny were administered
tamoxifen (for 4 consecutive days) when adults. In mice that were
killed immediately after induction (day 0), almost all NOS1-
expressing neurons were labeled with tdTomato expression (Fig.
2A). However, in mice that were killed 7 d after the tamoxifen
treatment, we observed the emergence of a population of NOS1-
expressing neurons that were not labeled with tdTomato (Fig. 2B),
suggesting that these NOS1-expressing neurons were newly born.
This observed loss of tdTomato-labeled nitrergic (NOS1+) neurons
was corroborated using our previously described technique of in
vivo imaging (32). On imaging the same myenteric region of live
NOS1-creERT2:tdTomato mice that were induced as before with
tamoxifen, we observed a loss of labeled neurons within a 24-h
period, accompanied by robust remodeling of neural networks (Fig.
2C). However, even with the observed loss of nitrergic neurons over
the course of 7 d, the total number of neurons within myenteric
ganglia was conserved (Fig. 2F) (mean numbers ± SE of HuC/D+
neurons per myenteric ganglia: 20.52 ± 1.58 vs. 19.33 ± 2.36 at day
0 and day 7, respectively). On the other hand, nearly a third (∼31%)
of preexisting NOS1 neurons labeled with tdTomato were lost at
day 7 (Fig. 2F) (mean numbers ± SE of tdTomato+ neurons per
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Fig. 1. Adult myenteric neurons undergo apoptosis-mediated cell death.
(A, i) Cells within the myenteric ganglia that express the apoptosis marker
cleaved caspase-3 (red) that (ii) also express HuC/D (green) represent apo-
ptotic neurons (yellow arrow) compared with other myenteric neurons do
not express cleaved caspase-3 (blue arrow). Nuclei are labeled with DAPI
(blue). (B) Nuclei labeled in vivo with PI (red) within the myenteric ganglia of
a ChAT-cre:YFP adult mouse, where cholinergic neurons are labeled with
YFP (yellow), represent neurons with leaky cell membranes indicating apo-
ptotic cells (dark-blue arrow). (C) Image of a myenteric ganglia of an adult
C57BL/6 mouse, where apoptotic cells were labeled with (i) CellEvent cas-
pase-3/7 detection dye (red) and then stained with (ii) HuC/D (green), shows
the presence of a population of myenteric neurons that are positive (red
arrows), as well as those negative for apoptotic markers (green arrows).
(iii) DAPI labeled nuclei (light gray). (Scale bars, 10 μm.)
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Fig. 2. Loss of myenteric neurons because of apoptosis can be quantified
and can be arrested using an antiapoptotic drug. (A and B) Images of
myenteric ganglia from an adult NOS1-creERT2:tdTomato mouse that was
killed the day after the cessation of tamoxifen induction (day 0) and stained
with antisera against NOS1 (green) (A) and another that was killed 7 d after
the cessation of tamoxifen induction (B). At day 0 (A), all NOS1-expressing
neurons express tdTomato (yellow arrows), whereas at day 7 (B), a pop-
ulation of NOS1-expressing neurons that do not express tdTomato emerges
(blue arrows). Nuclei are labeled in B with DAPI (blue). (Scale bars, 10 μm.)
(C) A 2D projection of 3D images captured using live animal two-photon
microscopy [(i) time 0 and (ii) time 24 h] from the same region of the
myenteric plexus of NOS1-creERT2:tdTomato mouse that was induced with
tamoxifen before the imaging shows the disappearance of a tdTomato+
nitrergic neuron (green arrow) within 24 h. The image also shows (white
arrow) the appearance of new projections from a tdTomato+ neuron that
rapidly extend to form new network connections within 24 h, showing the
robust plasticity of neuronal networks in the myenteric ganglia. (Scale bars,
10 μm.) (D and E) Representative images from myenteric ganglia that were
stained with antisera against HuC/D (green) and antibody against cleaved
caspase-3 (red) shows a lack of cleaved caspase-3 immunoreactivity in mice
that were given the pan-caspase inhibitor zVAD-FMK (E), whereas mice that
were not given the drug shows the presence of cleaved caspase-3–labeled
myenteric neurons (yellow arrow in E). (Scale bars, 10 μm.) (F) Quantification
of numbers of tdTomato+ and HuC/D expressing neurons within myenteric
ganglia from three different cohorts of mice killed at day 7 shows a signif-
icant reduction (*P < 0.05) in the numbers of tdTomato+ neurons per ganglia
in mice without zVAD-FMK compared with either day 0 or those given
zVAD-FMK. The data also shows that total numbers of HuC/D+ neurons
within myenteric ganglia remain conserved between days 0 and 7 (with-
out zVAD-FMK) although the numbers of tdTomato+ neurons dwindle.
Furthermore, an attenuation of apoptosis brought about by zVAD-FMK
administration results in a concomitant significant increase in total num-
bers of myenteric neurons per ganglia (#P < 0.05) compared with the other
two groups.
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myenteric ganglia were reduced by ∼31% at day 7: 3.70 ± 0.38;
compared with mice at day 0: 5.31 ± 0.42, P = 0.003).
To determine whether the observed loss of mature tdTomato+
neurons was because of apoptosis, we repeated the above experi-
ment in another cohort of NOS1-creERT2:tdTomato mice, this time
treated with the pan-caspase inhibitor zVAD-FMK for 7 d, which
suppressed the formation of cleaved caspase-3 within the adult
myenteric ganglia (Fig. 2 D and E). Furthermore, in NOS1-
creERT2:tdTomato mice induced with tamoxifen as before, this
treatment significantly attenuated the previously noted loss of
tdTomato-labeled nitrergic neurons (Fig. 2F) (mean numbers ± SE
of tdTomato+ neurons per myenteric ganglia in pan-caspase inhib-
itor treated mice at day 7 posttamoxifen: 5.20 ± 0.50). As predicted,
this arrest in death of nitrergic neurons also resulted in a significant
increase in the global numbers of neurons (as measured by HuC/D+
expression) (Fig. 2F) (mean numbers ± SE of HuC/D+ neurons in a
ganglia: 31.39 ± 1.57 vs. 19.33 ± 2.36 at day 7 posttamoxifen with
and without zVAD-FMK, respectively; P = 0.004).
Myenteric Neurons Are Continuously Phagocytosed by Muscularis
Macrophages in the Healthy Gut. We asked how dying neurons or
neuronal debris resulting from this high rate of neuronal death are
cleared away from the myenteric ganglia. Such a high rate of neu-
ronal death necessitates an equally efficient method of clearance by
phagocytic cells. A specialized subset of intestinal macrophages,
known as muscularis macrophages, are anatomically and functionally
associated with the myenteric plexus (33, 34). Because macrophages
do not express the gene for choline acetyltransferase (ChAT) (35,
36), which is expressed by a large number of myenteric neurons (35),
we used the ChAT-cre:tdTomato mouse to observe the phagocytosis
of myenteric neurons by muscularis macrophages. On imaging the
myenteric plexus of these mice when stained with antibodies against
macrophages, we observed that cell bodies of tdTomato-expressing
cholinergic neurons were engulfed by muscularis macrophages in
both the small intestine and the colon (Fig. 3, Fig. S1 C and D, and
Movie S1). Although we were able to observe engulfment of neurons
by these macrophages through microscopy, we also studied the
presence of tdTomato inclusions in intestinal macrophages using
flow cytometry and found that although the mucosal and submucosal
macrophages that are less associated with enteric neurons (33)
showed a very small population of tdTomato-containing macro-
phages, significant numbers (∼7.5%) of myenteric plexus-associated
muscularis macrophages contained tdTomato in both small and
large bowel, further supporting our imaging data (Fig. S1 E and F).
Taking these data together, we observed that ENS-associated mus-
cularis macrophages participate in phagocytosis of dying neurons
and the active clearance of neuronal debris, and that this process is
common for the both the small and large bowel.
Nestin Marks Putative ENPCs. Together, the above-mentioned results
on conservation of total neuronal numbers, despite significant on-
going neuronal loss, provide robust evidence of significant neuronal
turnover in healthy tissue, thereby indicating an active pool of ENPC.
We next identified such cells using Nestin, a cytoskeletal protein (37)
that is expressed by a variety of neural stem cells (38–42). tdTomato+
neurospheres derived from the longitudinal muscle-myenteric plexus
(LM-MP) layer of small intestines from tamoxifen-induced Nestin-
creERT2:tdTomato mice (where tdTomato expression in the myen-
teric plexus correlated with Nestin expression, Fig. S2A) differenti-
ated into neurons in vitro and expressed neuronal NOS1, an
enzyme characteristically expressed by inhibitory enteric neurons
(Fig. 4A). Furthermore, cells from these tdTomato+ neurospheres,
when transplanted into the wall of adult mice, successfully
engrafted and differentiated into HuC/D-labeled neurons in the
myenteric ganglia of the host mice (Fig. 4B and Fig. S3A).
Anatomical Location of ENPC in the Adult Intestine. Having proven
that Nestin is a suitable marker for ENPC, we then proceeded to
determine the location of putative ENPC in vivo using a Nestin-
GFP transgenic reporter mouse that one of our laboratories has
previously described (39). Using previously described techniques
for optical clarification-aided microscopy of intestinal tissue (43),
Nestin-GFP+ cells in these mice form an extensive network of cells
(Fig. 5 A and B and Movie S2) spanning most of the entire wall of
the small intestine. They are particularly prominent in the sub-
mucosal zone and in the muscular layers, but are not present in
the epithelial lining. Although, much of this network is peri-
vascular in nature (Fig. 5B), a smaller collection of cells is present
in the myenteric plexus (Fig. 5 A and B and Movies S2 and S3).
Because enteric neurons and their precursors are derived from the
neural crest (44, 45), we used a triple transgenic mouse (Wnt1-cre:
tdTomato)-(Nestin-GFP) to establish the origin of Nestin-GFP+
cells. Perivascular Nestin-GFP+ cells are not labeled with tdTomato
(Fig. 5C; unmerged images in Fig. S4A), and hence do not qualify
as neural crest-derived precursors. Instead, they express NG2 (Fig.
S4B), a characteristic marker of intestinal pericytes derived from
serosal mesothelium (46). In contrast, Nestin-GFP+ cells in the
myenteric plexus are labeled with Wnt1-cre:tdTomato, indicating
their origin from the neural crest. The intraganglionic Nestin-
GFP+ cells do not express the pan-neuronal marker PGP9.5 (Fig.
5D) and instead surround neuronal cell bodies (Fig. S5C and
Movie S3). However, they express the low-affinity nerve growth
factor receptor, p75NTR (Fig. 5E; unmerged images in Fig. S4D),
CD49b (Fig. 5F; unmerged images in Fig. S4C), and the glial
marker, S100β (Fig. S5C), both of which are known to mark cells
that give rise to enteric neurons and glia or neurospheres in vitro
(7, 8, 13). In contrast, perivascular Nestin-GFP+ cells do not ex-
press p75NTR. Finally, Nestin+ cells express the mitotic marker
Ki67 at steady state (Fig. 5G; unmerged images in Fig. S4G)
(mean ± SE numbers of myenteric ganglia with Nestin-GFP+ cells
A (i) A (ii)
B (i) B (ii)
Fig. 3. Muscularis macrophages phagocytose myenteric neurons in healthy
guts. (A, i) Two-photon microscopy of myenteric plexus from the colon of a
ChAT-cre:tdTomato mouse shows tdTomato-expressing (red) cholinergic
neurons along with MHC class II-labeled muscularis macrophages (green)
shows an abundance of macrophages associated with the myenteric plexus.
Inset (i) is magnified and shows (ii) the engulfment of tdTomato-expressing
neuronal soma (red) in MHC II labeled macrophages (green; cyan arrows).
(Scale bar, 50 μm.) (B, i) A 2D projection image of a z-stack of confocal mi-
croscopy images of neurons within the small intestinal myenteric ganglia
shows the colocalization of ChAT-cre:tdTomato (red) signal along with that
of CD11b-stained (green) muscularis macrophages. Inset (i) is magnified and
shows (ii) the engulfment of tdTomato-expressing neuronal soma (red) by
CD11b-stained macrophages (green; cyan arrows), suggesting phagocytosis
of myenteric neurons by macrophages. (Scale bar, 10 μm.)
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that coexpress Ki67: 0.44 ± 0.14), suggesting that these cells are
actively proliferating.
Myenteric Nestin+/p75NTR+ Express Stem Cell Behavior in Vitro.
Having established the location of these putative ENPC, we next
obtained definitive proof of their stem cell-like behavior using
in vitro clonal assays in a defined culture medium (12, 40). By
establishing the flow gates for p75NTR-expressing cells (Fig. 6A),
we confirmed the coexpression of p75NTR in a subset of Nestin-
GFP+ cells using FACS analysis (Fig. 6B and Fig. S2B). In vitro
clonal analyses on all isolated myenteric cell populations showed
that only Nestin-GFP+ cells proliferated (Fig. 6C) (mean ± SE of
percentage of neurosphere-forming Nestin-GFP+ cells: 3.6 ± 0.4).
Using similar clonal analysis on Nestin-GFP+ cells stained for
p75NTR, we found that only cells labeled for both Nestin-GFP+
and p75NTR+ formed neurospheres (Fig. 6D). This population
shows significant enrichment in the numbers of neurosphere-
forming cells over its parent population of all Nestin-GFP+ cells
(mean ± SE of percentage of neurosphere-forming proliferative
cells when sorted for Nestin-GFP and p75NTR: 10.1 ± 0.5; P <
0.01). Furthermore, these single cell-derived neurospheres pro-
duced both neurons and glia in differentiating conditions (Fig. 6E;
unmerged monochrome images in Fig. S4K) (mean ± SE of per-
centage of neurospheres that differentiate to form both neurons
and glia: 78.26 ± 4.35; only neurons: 0 ± 0; only glia: 2.22 ± 1.96).
Myenteric Nestin+ Cells Are Responsible for Neurogenesis in Vivo.
Having shown their potential as precursors in vitro, we then
tested whether myenteric Nestin-expressing cells are capable of
neurogenesis in vivo in healthy adult gut using inducible Cre
transgenic mice for fate-mapping experiments. Twelve hours after
tamoxifen induction, adult Nestin-creERT2:tdTomato mice did
not show any expression of tdTomato in existing HuC/D+ neurons
(Fig. 7A). However, 6 d after tamoxifen induction, adult myenteric
neurons were labeled with tdTomato, proving their derivation
from Nestin-expressing cells (Fig. 7B; unmerged images in Fig.
S4H). To further quantify this phenomenon, we killed a cohort of
mice 12 h, 24 h, 6 d, and 14 d after tamoxifen injection and found
an increase in the proportion of tdTomato+ neurons in myenteric
ganglia with time (Fig. 7C) (mean ± SE of mean percent of
tdTomato+ neurons/ganglia: 12 h: 0.0 ± 0.0; 24 h: 0.20 ± 0.20; 6 d:
3.62 ± 2.54; and 14 d: 6.87 ± 1.89, P < 0.05). Some Nestin-derived
cells in the myenteric ganglia also expressed S100β, showing that
these precursors can generate asymmetrical progenies (Fig. S4 E
and F).
New Neurons Arise from Precursors That Undergo Proliferation and
Cell Division.Given that Nestin+ cells proliferate in vivo (Figs. 5G
and 7D, and Fig. S5 A and B), we hypothesized that they can give
rise to new neurons in a classic stem cell paradigm where the
precursor cell divides to form a daughter cell that then differen-
tiates into a neuron, rather than by direct transdifferentiation
without an intermediate cell division. We therefore determined if
mature neurons were derived from proliferating cells, which would
indicate the former process. Under resting conditions, a stem cell
divides asymmetrically to produce a precursor cell and another
stem cell. The former goes on to differentiate into a mature cell,
whereas the latter reenters the cell-cycle after a period. Hence, by
using temporally spaced proliferation markers, both the original
stem cell and its daughter stem cell can be labeled and their fate
followed in vivo.
We first optimized experimental protocols to detect thymidine
analogs by using a variety of denaturation protocols (47) and
then tweaking them for sectioned and whole-mount intestinal
tissue. We administered IdU to an adult C57/Bl6 mouse for
7 consecutive days through drinking water and killed it at the end
of 7 d of treatment. After rigorous denaturation (100 mM citrate
buffer, pH 6.0, boiled for 2.5 min) of the tissue, IdU-labeled cells
within the myenteric plexus were found within cross-sections of
the ileum that expressed the pan-neuronal marker PGP9.5, and
hence were neurons (Fig. 8A and Fig. S4 I and J). Cells within the
intestinal crypts were also found to be labeled with IdU (Fig. 8A)
validating our method.
Nestin-creERT2:tdTomato mice were then given a single dose
of tamoxifen, followed a day later by a week-long pulse of IdU and
in turn followed by a week-long pulse of a different thymidine
analog, CldU, immediately after which the mice were killed. Both
IdU and CldU are detected by anti-BrdU antibodies that selec-
tively cross-react to either IdU or CldU (48). If our hypothesis was
correct, then during the first week, stem cells should take up IdU,
and if they undergo asymmetrical division, then both the differ-
entiated and the daughter stem cells will be labeled with IdU.
Subsequent exposure to another label (CldU) will then result in
only the proliferating daughter stem cell to carry both (IdU and
CldU) labels that will in turn be expressed by their differentiated
progeny cells. Fig. 8B shows a Nestin-derived (tdTomato+) neuron
that stains for both IdU and CldU, suggesting that this particular
B(i)
A(ii)
A(iv)A(iii)
B(ii)
A(i)
Fig. 4. Nestin marks putative enteric neuronal precursor cells in the adult
gut wall. (A) In vitro cultured neurosphere-derived neurons from a Nestin-
creERT2:tdTomato mouse that (i) are stained with NOS1 (green) and (ii) ex-
press tdTomato (red) under Nestin-creERT2induction, (iii) show colocalization
providing evidence that Nestin-expressing cells generate neurospheres in
culture that can be differentiated into nitrergic neurons; (iv) nuclei are
stained with DAPI (blue). (Scale bars, 10 μm.) (B) Myenteric ganglia of an
adult mouse where Nestin-creERT2:tdTomato-derived neurosphere-derived
cells were transplanted where (i) tdTomato+ graft derived cells (red; white
arrow) (ii) form mature neurons that express HuC/D (magenta; white arrow),
showing that graft-derived cells give rise to neurons. Additional tdTomato-
expression can be noticed (red arrow) which does not show corresponding
HuC/D colocalization. HuC/D and tdTomato channels separated in Fig. S3A.
Nuclei are counterstained with DAPI (blue). (Scale bars, 10 μm.)
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neuron was derived from a Nestin-expressing ENPC that cycled
at least twice in the 2 wk after tamoxifen induction to generate
a neuron.
As shown in Fig. 8C, of all of the HuC/D+ neurons, an average
of 11.5% of neurons had no label, and hence were born before the
2-wk experiment; an average of 17% were only labeled with IdU
and therefore were born from cells that cycled in the first week;
66% were labeled with both IdU and CldU, and therefore were
born from cells that cycled at least twice in 2 wk and 4.75% were
labeled with only CldU, suggesting that they were born from cells
that cycled in the second week and had either already diluted their
IdU label or never had it to begin with. Thus, ∼88% of all
myenteric ganglia neurons that were labeled with HuC/D are only
2-wk-old, indicating a high rate of neurogenesis. Despite the evi-
dence of copious neurogenesis, we found as before (Fig. 2F), that
the numbers of neurons in myenteric ganglia remains constant
during this entire time (Fig. 8D), consistent with ongoing attrition
from apoptosis shown previously.
Targeted Deletion of Phosphatase and Tensin Homolog in Adult ENPCs
Reproduces the Phenotype of Some Forms of Chronic Intestinal Pseudo-
Obstruction. If enteric neurons are derived from proliferating
Nestin+ cells, then changes in their cycling behavior should disrupt
ENS morphology and function. We have previously shown that
changes in phosphatase and tensin homolog deleted on chromo-
some 10 (PTEN) signaling in putative adult ENPC in an in vitro
model results in increased ENPC proliferation (40). We therefore
deleted the PTEN gene in adult Nestin-expressing cells using
Nestin-PTEN cKO mice. After tamoxifen induction, small in-
testinal myenteric ganglia in the Nestin-PTEN cKO mice were
larger than those in the Nestin-PTEN WT mice (Fig. 9 A and B),
with a significant increase in both the average numbers of neurons
per ganglia (n = 3 mice per group, mean ± SE numbers neurons
per ganglia: 17.79 ± 1.3 and 41.25 ± 3.4 for PTENWT and PTEN
cKO, respectively, P = 0.003) (Fig. 9C) and the size of neuronal
soma [n = 3 mice per group, mean ± SE soma size (measured as
Feret diameter): 15.4 ± 0.44 μm and 20.00 ± 0.41 μm for PTEN
WT and PTEN cKO, respectively, P = 0.001] (Fig. 9D). In addi-
tion, we found that the whole-gut transit time for PTEN cKOmice
was significantly more than PTEN WT animals (n = 8 mice per
PTEN cKO group and n = 3 per PTEN WT group, mean ± SE
gastrointestinal transit time of dye: 158.8 ± 20.17 min and 231.7 ±
14.33 min for PTEN WT and PTEN cKO, respectively; Mann–
Whitney test: P = 0.04) (Fig. 9E).
Relationship of ENPC to Glia. Given their expression of S100β, it is
conceivable that ENPC are glial cells. To test this hypothesis, we
studied the coexpression of Nestin and Sox10. Sox10 is expressed
by neurogenic migrating ENPC during embryogenesis and devel-
opment, but in adults it only marks mature enteric glia (8, 44). For
this experiment, we used adult Sox10-H2BVenus mice, in which all
myenteric Sox10-expressing cells are labeled with the fluorescent
reporter protein Venus (44). When stained for Nestin, myenteric
ganglia from these mice showed no detectable overlap between
Sox10 and Nestin (Fig. S6A). We further tested the expression
of conventional glial markers GFAP and S100β in the Nestin-
GFP+/p75NTR+ ENPC population in adult mice using FACS
analysis. Although Nestin-GFP+ p75NTR+ cells express GFAP
and S100β, not all GFAP+ or S100β+ cells expressed either Nestin-
GFP or high levels of p75NTR (Fig. S6 B–G). Thus, expression of
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Fig. 5. Distribution of proliferative neural crest-derived putative enteric neural precursor cells in the gut wall. (A) A 3D projection image of the gut wall from
a Nestin-GFP reporter mouse, where blood vessels are perfusion-painted with DiD (cyan) and nuclei are counterstained with PI (light gray), showing that cells
expressing Nestin-GFP (green) form an extensive network that is present in many layers of the gut, ranging from the longitudinal and smooth muscle layer
(labeled as LM and SM, respectively) to the mucosa (labeled M). (B) A 3D projection of the Nestin-GFP cell network within the gut wall of the adult ileum
without vessel and nuclear stain (with longitudinal and smooth muscle layer labeled as LM and SM, respectively, and the mucosa is labeled M). White arrows
in A and B both point toward the location of the myenteric ganglia. Images A and B captured using a 10× objective lens. (C) Image from the myenteric plexus
of a Wnt1-cre:tdTomato mouse containing a Nestin-GFP transgene showing that only the Nestin-GFP–expressing cells in the myenteric ganglia (red arrow),
and not perivascular cells (green arrow), are of neural crest origin. (D) Intraganglionic Nestin-GFP+ cells (green, green arrows) do not express pan-neuronal
marker PGP9.5 (magenta, yellow arrow) in a mouse whose vasculature was labeled with DiD (red) indicating that intraganglionic Nestin-GFP expression does
not label neurons. (E) Only a subpopulation of Nestin-GFP+ cells (green cells) present within the myenteric ganglia and not on the periphery of blood vessels
(red) express the low-affinity nerve growth factor receptor p75NTR (magenta), with yellow arrows here labeling some of the double-positive cells. Some
p75NTR-expressing cells within the myenteric ganglia do not express Nestin-GFP (*), whereas some other cells express neither Nestin-GFP nor p75NTR (#).
(F) Similarly, a population of intraganglionic Nestin-GFP+ cells (green cells) express CD49b (magenta) with yellow arrows here labeling some of the double-
positive cells. (G, i) Myenteric ganglia from the ileum of a Nestin-GFP transgenic reporter mouse where Nestin-expressing cells express GFP (green) shows
Ki67+ cells (red; yellow arrows) that also express Nestin-GFP; (ii) DAPI (blue) labeling of nuclei shows that the Ki67+ Nestin-GFP cells (yellow arrows) show a
different staining profile compared with other cells. (Scale bars in C–G, 10 μm.)
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GFAP or S100β by themselves is not sufficient to identify the adult
ENPC. Our results, together with data from other studies (49, 50),
suggests that true glia express Sox10, whereas ENPC do not. Adult
ENPC are therefore not enteric glia, although they express certain
genes also associated with enteric glia.
Discussion
Although neurogenic cells have been shown to exist in adult mu-
rine and human gut, the demonstration of their stem-cell like
behavior has been mainly restricted to in vitro experiments (7, 12,
13, 22, 40, 51–53). Until now, most studies have suggested that
there is no adult enteric neurogenesis in vivo in the healthy gut
(7–9, 54). However, in the presence of ongoing neuronal loss and
degeneration, as shown in a recent report (27), we do not know
how adult myenteric neuronal numbers can be maintained for
much of the adult life. Given the conflicting reports on this topic in
the literature (5, 6, 26, 55–58), it was first important to rigorously
establish and quantify apoptosis in adult enteric neurons. The use
of multiple protocols for testing the presence of apoptotic neurons
allowed us to confidently prove a high rate of myenteric neuronal
apoptosis in the healthy gut. Approximately 11% of myenteric
neurons at any one time are labeled by cleaved caspase-3, sug-
gesting that they are fated for programmed cell death. We also
found that significantly high (∼31%) numbers of labeled neurons
were lost in a 7-d period, translating into a 4–5% loss of per day.
The fact that approximately half the numbers that are fated for
apoptosis (by cleaved caspase-3 labeling) die daily implies that it
takes about 2 d for a neuron to die after initiation of apoptosis,
which is consistent with what has been previously reported for
other kinds of neurons (59). The physiological role of apoptosis
was highlighted by the use of a caspase inhibitor, which resulted in
an increase in myenteric neuronal counts. Finally, we also show
the presence of a robust phagocytic response driven by the
abundant numbers of muscularis macrophages, which are known
to be associated with myenteric neurons (33), to clear the debris
left from the significant numbers of dying neurons.
Together, these results show a high turnover of enteric neurons
in the adult gut, which can only be reconciled by invoking ongoing
neurogenesis, which in turn necessitates the existence of an ENPC.
Previous attempts to define adult ENPC have relied on in vitro
demonstration of stem-cell like behavior of cells expressing vari-
ous markers, such as Sox10, GFAP, p75NTR and CD49b, and
Nestin (7–9, 11–18, 20–23). Among these markers, we focused on
Nestin because of the existence of transgenic animals expressing
the Cre recombinase enzyme under the nestin promoter, allowing
us to visualize and isolate these cells, follow their fate in vivo and
genetically manipulate the expression of other proteins in them
(38, 39, 41, 42). Using Nestin-GFP transgenic reporter mice, we
show that cells that coexpress Nestin with the neural crest stem
cell marker, p75NTR, do not express neuronal markers and are
located within the myenteric ganglia. This is the only cell pop-
ulation that is capable of proliferation and neurogenesis in vitro in
defined culture conditions. By following the fate of these cells in
adult inducible Nestin-creERT2:tdTomato mice, we found that
Nestin-expressing cells gave rise to adult myenteric neurons in the
healthy gut, suggesting that these cells are the true ENPC. A
previous study has described a putative ENPC in the adult murine
colon and suggested proliferation and migration into the myen-
teric plexus from an extraganglionic location after treatment with
a 5HT4 agonist (9). More recently, extraganglionic Schwann cell
precursors were observed to generate myenteric neurons in the
colon, but not in the small intestine (45). In contrast to these two
studies, we show that adult Nestin+ precursors for small intestinal
myenteric neurons are present inside the myenteric ganglia, sug-
gesting regional differences in enteric neurogenesis.
Our results also suggest that true ENPC are not mature enteric
glia, as was previously suggested (60). Although Sox10-expressing
cells in the adult myenteric plexus layer retain neurogenic prop-
erties in vitro (44), such ability in vivo at steady state remains re-
stricted to embryonic and early postnatal stages (8). Somewhere
between the two phases of embryonic ENS “development” and
adult ENS “maintenance,” there is a switch in ENPC marker
profile from Sox10 to Nestin. Indeed, recent work in zebrafish ENS
development shows that the neural precursors in the developing
gut are also heterogeneous for their Sox10 expression, with neu-
rogenic Sox10− cells present behind the migrating wave front of
Sox10+ multipotent enteric neural crest precursors (61). Together
with our findings, these reports lead to a plausible hypothesis that
Sox10+ mature glial cells in the adult gut have restricted ability to
generate neurons in vivo and only under certain injurious condi-
tions (8), whereas Nestin+/Sox10− precursors are responsible for
adult neurogenesis in health.
Definitive proof of the precursor nature of these cells was their
ability, under conditions that promoted unchecked proliferation,
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Fig. 6. The ability for in vitro proliferation and neurogenic differentiation is restricted to myenteric cells that coexpress Nestin-GFP and p75NTR. (A) p75NTR
immunostaining labels most cells positive at varying intensities (blue curve) compared with unstained cells shown here in a red-shaded curve, but only highly labeled
cells (10.2% of cells) are deemed positive. These data are used for setting up the flow sorting gates for p75NTR+ population. (B) Cells flow-sorted for their Nestin-GFP
and p75NTR staining according to the gates set in the four quadrants. (C) In vitro clonal analyses performed in completely defined medium of flow sorted single cells
from the LM-MP layer of a Nestin-GFP reporter mouse shows that only Nestin-GFP expressing cells harbored proliferative potential. (D) In vitro clonal analyses
performed in completely defined medium of flow sorted single Nestin-GFP–expressing cells stained with antibodies against p75NTR shows that Nestin-GFP and
p75NTR coexpressing cells alone have the proliferative potential. (E) The clonally derived neurospheres were differentiated in defined culture medium containing
Neurobasal medium, B27, BSA, and β-mercaptoethanol, but without growth factors, to generate differentiated cells, some of which showed (i) continued expression
of Nestin-GFP (green), whereas others gave rise to (ii) PGP9.5-expressing neurons (red, red arrow), which did not show Nestin-GFP coexpression, or (iii) GFAP-
expressing cells (blue) that may show colocalization of Nestin-GFP (green arrow). Nuclei are labeled with DAPI (iv), shown here in light-gray color. (Scale bars, 10 μm.)
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to reproduce the phenotype of certain human diseases. A change
in enteric neuronal number is associated with chronic intesti-
nal pseudo-obstruction, a chronic debilitating condition with
slow intestinal motility and related complications. Both decreases
(hypoganglionisis) and increases (hyperganglionosis) in myenteric
neurons have been associated with chronic intestinal pseudo-
obstruction. The latter include several human conditions, such as
intestinal neuronal dysplasia (IND) or ganglioneuromatosis, which
are probably heterogeneous disorders with subsets of patients
showing marked reduction in the expression of PTEN (24). Taken
together with our previous in vitro results that adult ENPC cycle
and generate neurons in a PTEN-dependent manner (40), the
present work suggests that adult neurogenesis in vivo may also be
controlled by a molecular pathway involving PTEN expression.
We recognize that our findings contradict current dogma in the
field, which postulates that populations of adult enteric neurons,
once born, remain static until death by disease or senescence.
Indeed, previous reports have apparently failed to find evidence of
neurogenesis by following the fate of adult Sox10-expressing cells
that were assumed to be adult ENPC (8). This discrepancy can
now be explained by our demonstration that ENPC do not express
Sox10. On the other hand, ENPC do express glial markers like
GFAP and others have attempted to use GFAP for fate-mapping
experiments in adult neurons, with results that also apparently
conflict with ours (7). These investigators used an adult inducible
transgenic hGFAP-creERT2 mouse bred with a floxed YFP re-
porter transgenic mouse on a B6 background that was given a
long-term exposure to tamoxifen (6–8 mo). However, only 3–5%
of GFAP+ cells actually underwent tamoxifen-induced cre re-
combination to become YFP+. Given this reduced rate of trans-
gene expression along with additional problems related to reporter
expression with age (62), it is not surprising that these investigators
saw a very small proportion of neurons that appeared to be derived
from adult GFAP-YFP+ cells. Furthermore, because all of the
tamoxifen-induced hGFAP-creERT2 mice were killed at the same
time of posttamoxifen treatment, Joseph et al. could not observe
whether or not this GFAP-derived neuronal population expands
with time (7). Nevertheless, the fact that such low numbers of
recombinant YFP+ cells were still able to generate a population of
neurons at steady state is consistent with our results.
In this report, we also addressed another discrepancy in the
literature, namely the inability by Joseph et al. (7) to demon-
strate in vivo neurogenesis using BrdU labeling. We next address
the issue of why previous reports, using BrdU pulse-chase tech-
niques, failed to demonstrate neurogenesis from cycling precursors
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Fig. 8. Label-retaining experiments show rapid and robust myenteric neuro-
genesis from proliferating Nestin-expressing precursor cells. (A, i) IdU staining,
following 100 mM citrate buffer denaturation of a cross-section (14-μm thick)
of ileum from an adult C57BL/6 WT mouse that was dosed with IdU for 7 d and
killed immediately after, shows expected positive staining in the intestinal
crypt (green arrow) along with staining in the LM-MP layer (red arrow, dashed
rectangle magnified in subsequent panels). (ii) PGP9.5 immunoreactive neuron
(green, red arrow), where nuclei are counterstained with DAPI (blue), (iii) is
also labeled with specific antibodies against IdU (red), suggesting the presence
of newborn neurons derived from precursor cells that cycled during the
IdU pulse. (Scale bars, 10 μm.) (B, i) CldU-labeled (green) and (ii) IdU-labeled
(red) cells that express (iii) HuC/D (blue) and (iv) tdTomato (cyan) are neurons
(yellow arrow) that are derived from tdTomato+ Nestin-expressing cells that
have cycled at least twice, during the IdU as well as CldU pulse to generate
neurons. Because of tamoxifen given at a clonal dose, only a subpopulation of
precursor cells and their derivative neurons express tdTomato. Same figure and
panels shows a neuron (red arrow) derived from a precursor cell that cycled
only during IdU pulse where presence of IdU (red) can be detected but no CldU
(green) can be detected. (Scale bars, 10 μm.) (C) The percentages of neurons
that are born with a single label (IdU+ or CldU+), hence derived from precursor
cells that cycled only once in either conditions, compared with neurons born
with both labels, and hence derived from precursor cells that cycled in both the
conditions to generate neurons. This finding suggests that the rate of cycling of
the precursor cells is high. We also see a small population of neurons born from
precursors that did not cycle during the experiment and hence were either
born during the experiment but from cells that cycled just before the experi-
ment or were born before the experiment. (D) In healthy adult mice, we ob-
serve that the mean numbers of neurons in myenteric ganglia of adult
littermates are highly conserved across 21 d of sampling.
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Fig. 7. In vivo neurogenesis from proliferating Nestin-expressing cells within
the adult myenteric ganglia. In a Nestin-creERT2:tdTomato mouse induced with
tamoxifen at clonal dose, we observe that (A) 12 h after tamoxifen induction,
tdTomato+ cells in the myenteric ganglia (red; red arrow) do not overlap with
the pan-neuronal marker HuC/D (green; green arrow), whereas (B) 6 d after
the induction, we observe a population of HuC/D+ (green) cells in the myen-
teric ganglia emerge that express tdTomato (red) and fluoresce yellow
(marked here by white arrow). The same ganglia also contain HuC/D-labeled
(green) neurons that are not derived from tdTomato-expressing cells (green
arrow). tdTomato+ cells that do not express HuC/D also persist in the myenteric
ganglia (red arrow). Nuclei in both images are counterstained using DAPI
(blue). (Scale bars, 10 μm.) Furthermore, (C) compared with 12- and 24-h
posttamoxifen induction, we observe an increase in the numbers of tdTomato
expressing HuC/D+ neurons at 6 and 14 d (*P < 0.05), suggesting continuing
derivation of neurons from Nestin-expressing cells. (D) tdTomato+ cells within
the myenteric ganglia proliferate in vivo, as indicated by their significant in-
crease in numbers 6 d after being labeled at a clonal dose (**P < 0.001).
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(7, 8, 54). We reasoned that if the ENPC population truly
has a high turnover rate, decay of label-retention marker to below
detection levels could have been a significant confounding factor
(63). We therefore designed a labeling and detection protocol for
shorter chases and harsher DNA denaturation. Using these tech-
niques for temporally dispersed administration of distinct thymi-
dine analogs, we show that adult enteric neurogenesis results from
cycling neural precursors that express Nestin. After 2 wk of treat-
ment with the thymidine analogs, ∼88% of all neurons that were
labeled with HuC/D showed evidence of label-retention, and hence
were newly born. Although this number is very high, it helps explain
how myenteric neuronal numbers can be maintained despite very
high rates of neuronal apoptosis. When apoptosis was arrested,
we saw an ∼50% increase in numbers of neurons per ganglia in a
week, which reconciles with ∼88% of newborn neurons in 2 wk.
The surprisingly high rate of neuronal turnover raises several
questions that remain to be answered in future studies. Our results
are confined to the small bowel and we do not know whether
other regions of the gut express the same paradigm of neuro-
genesis. Our results with in vivo imaging show a rapidly changing
neuronal network, indicating a highly dynamic nervous system that
is constantly losing old connections and making new ones. At this
time we do not fully understand how functional circuits are built or
maintained in the ENS, but a likely explanation for the lack of
physiological disruption from this turnover is that it is staggered in
time and space, along with the significant redundancy of such
circuits within a given region of the gut (64–67).
This rate of turnover in the ENS is either a result of an in-
trinsically short life of mature neurons or of injury from constant
mechanical stress (tensile, compressive, and shear) exerted on the
myenteric plexus by virtue of it being sandwiched between the
longitudinal and circular muscle (3). In addition, because of its
proximity to bowel contents, the ENS is uniquely vulnerable to
external threats (4, 68). Nevertheless, a relatively small population
of ENPC in the myenteric ganglia appears to be capable of
replacing large numbers of dead or dying neurons. As our previous
calculations show, adult myenteric neurons die at a rate of a single
neuron per ganglia per day, which is not beyond the capacity of a
rapidly cycling cell. An alternative mechanism involves a pool of
intermediate “transit-amplifying” cells that are fate-committed
and cycle to generate large numbers of terminally differentiated
cells, as is done by the intestinal stem cells (69). Whether such
neurogenic transit-amplifying cells exist in the adult myenteric
ganglia is not currently known, and understanding the differenti-
ation pattern of ENPC to form adult neurons would be part of the
next steps in understanding the complex biology of the adult ENS.
In conclusion, our study shows evidence of a robust and rapid
turnover of adult enteric neurons from identifiable neuronal
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Fig. 9. Knocking out PTEN in adult ENPC significantly increases neuronal numbers and size with a significant increase in whole-gut transit time. (A and B)
Photomicrographs showing HuC/D stained (green) neurons in the myenteric ganglia of Nestin-PTEN WT and Nestin-PTEN cKO mice, respectively, 30 d after
induction with tamoxifen. Nuclei are counterstained with DAPI (blue). (Scale bars, 10 μm.) We observe that (C) there are significantly more HuC/D+ neurons in
the myenteric plexus of the Nestin-PTEN cKO mice compared with their WT control Nestin-PTEN WT mice, and that (D) the mean size of neurons (denoted by
Feret diameter: diameter of the neuronal cell soma) is significantly higher in Nestin-PTEN cKO mice, than in their WT controls (P < 0.05). (E) Nestin-PTEN cKO
mice 30 d after induction with tamoxifen show a significantly increased whole-gut transit time of carmine red dye compared with age-matched Nestin-PTEN
WT mice that were similarly induced with tamoxifen (P = 0.04).
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precursors that are not mature glial cells (Fig. S7). These findings
have considerable scientific and clinical significance. Reliance on this
mechanism to maintain neuronal numbers in the presence of ongoing
apoptosis may render the ENS at risk from disturbances in this
process. For example, a recent study shows that the anticancer
chemotherapeutic agent 5-FU, a thymidine synthesis blocker that
targets cycling cells, causes a reduction in populations of adult
myenteric neurons (70). Similarly, reports of increased apoptosis in
myenteric neurons in adult mice with high-fat diet-induced obesity
(58) are not always associated with a corresponding loss of myen-
teric neurons, suggesting active replacement (71). In another case
of clinical and physiological relevance, aging is associated with both
decreased presence (72) and proliferative potential of ENPC,
as well as increased neuronal apoptosis (27), which together
could account for the observed reduction in neuronal numbers
with age (64). These reports can now be better understood in a
construct where the ENS is dynamically maintained by a bal-
ance between apoptosis and neurogenesis. Furthermore, as we
have shown, targeting genetic mutations in the identified ENPC
has the potential for developing novel models of human dis-
ease. Therefore, by identifying the participating cells and their
molecular profile, our study provides a scientific foundation to
study the pathogenesis of disorders of motility, as well as
therapeutic targets for the same.
Methods
Animals. All mice used for the experiments were between the ages of 8 and
24wk and are designated as adultmice. Experimental protocols were approved
by Stanford University’s Administrative Panel on Laboratory Animal Care,
Pennsylvania State’s Institutional Animal Care and Use Committee (IACUC),
Vanderbilt University’s IACUC, Duke University IACUC, as well as by The Johns
Hopkins University’s Animal Care and Use Committee in accordance with the
guidelines provided by the National Institutes of Health. Details of WT and
transgenic mice used for the experiments are presented in SI Methods.
Protocols for tamoxifen induction; cell culture and transplantation experiments.
These methods are expanded in SI Methods.
Tissue preparation, cell isolation experiments. Tissue preparation was performed
as described before (12, 40), which along with immunohistochemistry (for anti-
bodies see Table S1) and cell isolation protocols are described in SI Methods.
Protocols for IdU and CldU labeling, detection, and quantification. Post tamoxifen
induction, the mice were given 1 mg/mL of IdU by drinking water for 7 d, after
which the IdU-laced drinking water was exchanged with drinking water con-
taining 1 mg/mL of CldU for 7 more days. The mice were then killed, and LM-MP
preparations (see below) fixed in freshly made ice cold 4% paraformaldehyde
solution. For thewhole-mount stainings, we tested denaturationwith 10% EDTA
(47) at both room temperature and at elevated temperatures (50 °C) for 15 min
and found the tissue unresponsive to any immunohistochemistry using either the
BrdU antibodies or the anti-HuC/D sera. These experiments with EDTA were
followed by testing CldU and HuC/D immunostaining with control tissue (from
animals without exposure to CldU) and test tissue (from animals dosed with CldU
for 1 wk) that were exposed to 2 N HCl at 50 °C for varying amounts of time (5,
10, and 15 min), and then were immediately washed after thrice with 1× PBS
(15 min per wash). The control tissues did not give any reaction to CldU anti-
bodies, whereas the test tissues saw an increase in the numbers of cells around
and within the myenteric ganglia with exposure to the denaturing agent (Fig. S3
B and C). Exposure to 2 N HCl at elevated temperatures beyond 15-min
hampered tissue integrity and created impediment to immunostaining and vi-
sualization. This standardized protocol was used for immunostaining the IdU/
CldU-stained tissues. IdU/CldU was then labeled with anti-BrdU antibodies that
selectively cross-label either IdU or CldU [B44 antibody selectively cross-reacts
with IdU (BD Biosciences) and Bu1/75 selectively cross-reacts with CldU (Novus
Biologicals)] (48) and counterstained with anti-mouse 546 antibody (against B44
IdU antibody) and anti-rat 488 antibody (against Bu1/75 CldU antibody) (Invi-
trogen). The acid treatment destroys all native fluorescence and changes cell
structure, so tdTomato expression needs to be revealed by immunofluorescence.
Hence, the tissues were stained with anti-RFP antibody (Rockland) in addition to
HuC/D antisera (ANNA1). The anti-RFP antibody was counterstained with anti-
rabbit 647 antibody (Invitrogen) and the HuC/D antisera was counterstained
with anti-human Brilliant Violet 421 antibody (Biolegend). The tissues were
mounted with mounting medium without DAPI (Vector Labs). Control tis-
sues of LM-MP that were never dosed with IdU/CldU were similarly dena-
tured and stained. Slight staining in the nucleoli was regarded as a
denaturation-based autofluorescence, but copious staining in the whole
nucleus in a HuC/D-labeled cell was deemed as a positively labeled neuron.
As a technical limitation of performing acid treatment, a prerequisite of
staining for label-retention, on whole mounts of intestines to visualize and
enumerate enteric neurons, the size and shape of cells is changed and not
all neurons are labeled with HuC/D. Hence, for the quantification, only
neurons labeled convincingly with HuC/D antisera are counted, and hence
represent a subpopulation of all myenteric neurons.
Detecting apoptosis in enteric neurons. Fixed LM-MP tissues from an adult C57BL/6
mouse were stained for cleaved caspase-3, a marker for apoptosis using the
antibody Asp175 (Cell Signaling). The tissues were counterstained with DAPI,
overlaid with Vectashield mounting medium (Vector Labs), coverslipped, and
imaged using a Leica 510 confocal microscope. The images then were analyzed
using Fiji software (fiji.sc). A HuC/D-labeled cell in the myenteric ganglia with
strong immunostaining for cleaved caspase-3 in the perinuclear space (26, 56,
73) was counted as an apoptotic neuron. Other methods for detecting apo-
ptotic neurons are presented in SI Methods. Small intestinal ganglia were
demarcated as previously described (27) and their neuronal density was rep-
resented as neurons/ganglia as previously reported (74).
Imaging experiments. Protocols for fixed tissue confocal imaging, live animal
confocal imaging, as well as two-photon imaging experiments are described
in SI Methods.
Statistics. All the quantified data is presented in Tables S2–S8. Data are
expressed as the mean ± SE for every graphical representation. Statistical
analysis was performed with the aid of Graphpad Prism. A Mann–Whitney test
and and Kruskall–Wallis test were used to compare means for statistically
significant difference between two and three groups, respectively. Statistical
significance (*) was assumed if P < 0.05.
ACKNOWLEDGMENTS. We thank Prof. Jeremy Nathans (The Johns Hopkins
University) and Prof. Ben Barres (Stanford University) for their scientific advice
and critical comments; Dr. Charles Chan (Stanford University) for help with
standardizing tissue digestion protocols; Dr. Martin Bigos for help with
standardizing flow-sorting protocols; and Mithra Kumar (The Johns Hopkins
University) for help with mouse colony management. FACS sorting was done
with the help of the Beckman Flow Sorting Core at Stanford University, and
FACS analysis was performed at the Ross Flow Sorting Core at The Johns
Hopkins University and at the Flow Cytometry Core Facility in the Department
of Comparative Medicine at the Pennsylvania State University. Confocal
microscopy was performed using the Ross Confocal Microscopy Core, the
MicFac at The Johns Hopkins University, the NIS microscopy facility at Stanford
University, Sravya Kurapati (Pennsylvania State Biomedical Sciences PhD
Program), and Thomas Abraham with the Microscopy Imaging Facility
(Pennsylvania State University College of Medicine). This work was supported
by National Institute of Diabetes and Digestive and Kidney Diseases Grant
R01DK080920 (to P.J.P.); Grant P30 DK089502 (Conte Digestive Diseases Basic
and Translational Research Core Center at the Johns Hopkins University); NIH
Grants OT2-OD023849 and R01GM114254 (to X.S.); Defense Advanced
Research Planning Agency Grant N660015-2-4059 (to X.S.); NIH Grants
R01DE022750 and R01GM087369 (to X.D.); a Johns Hopkins University Brain
Science Institute grant and the Howard Hughes Medical Institute (to X.D.); an
innovation award from the Kenneth Rainin Foundation (to M.B.); National
Institute of Allergy and Infectious Diseases Grant R21 AI126351 01 (to M.B.);
and March of Dimes Grant 1FY-12-450) (to E.M.S.-S.).
1. Furness JB (2012) The enteric nervous system and neurogastroenterology. Nat Rev
Gastroenterol Hepatol 9:286–294.
2. Ouyang A, Locke GR, 3rd (2007) Overview of neurogastroenterology-gastrointestinal
motility and functional GI disorders: Classification, prevalence, and epidemiology.
Gastroenterol Clin North Am 36:485–498, vii.
3. Mazzuoli-Weber G, Schemann M (2015) Mechanosensitivity in the enteric nervous
system. Front Cell Neurosci 9:408.
4. Anitha M, et al. (2016) Intestinal dysbiosis contributes to the delayed gastrointestinal
transit in high-fat diet fed mice. Cell Mol Gastroenterol Hepatol 2:328–339.
5. Gabella G (1971) Neuron size and number in the myenteric plexus of the newborn
and adult rat. J Anat 109:81–95.
6. Thrasivoulou C, et al. (2006) Reactive oxygen species, dietary restriction and neuro-
trophic factors in age-related loss of myenteric neurons. Aging Cell 5:247–257.
7. Joseph NM, et al. (2011) Enteric glia are multipotent in culture but primarily form glia
in the adult rodent gut. J Clin Invest 121:3398–3411.
8. Laranjeira C, et al. (2011) Glial cells in the mouse enteric nervous system can undergo
neurogenesis in response to injury. J Clin Invest 121:3412–3424.
9. Liu MT, Kuan YH, Wang J, Hen R, Gershon MD (2009) 5-HT4 receptor-mediated
neuroprotection and neurogenesis in the enteric nervous system of adult mice.
J Neurosci 29:9683–9699.
10. Pham TD, Gershon MD, Rothman TP (1991) Time of origin of neurons in the murine
enteric nervous system: Sequence in relation to phenotype. J Comp Neurol 314:789–798.
Kulkarni et al. PNAS | Published online April 18, 2017 | E3717
N
EU
RO
SC
IE
N
CE
PN
A
S
PL
U
S
11. Almond S, Lindley RM, Kenny SE, Connell MG, Edgar DH (2007) Characterisation and
transplantation of enteric nervous system progenitor cells. Gut 56:489–496.
12. Becker L, Kulkarni S, Tiwari G, Micci MA, Pasricha PJ (2012) Divergent fate and origin
of neurosphere-like bodies from different layers of the gut. Am J Physiol Gastrointest
Liver Physiol 302:G958–G965.
13. Bixby S, Kruger GM, Mosher JT, Joseph NM, Morrison SJ (2002) Cell-intrinsic differ-
ences between stem cells from different regions of the peripheral nervous system
regulate the generation of neural diversity. Neuron 35:643–656.
14. Bondurand N, Natarajan D, Thapar N, Atkins C, Pachnis V (2003) Neuron and glia
generating progenitors of the mammalian enteric nervous system isolated from
foetal and postnatal gut cultures. Development 130:6387–6400.
15. Heanue TA, Pachnis V (2010) Prospective identification and isolation of enteric ner-
vous system progenitors using SOX2. Stem Cells 29:128–40.
16. Lo L, Anderson DJ (1995) Postmigratory neural crest cells expressing c-RET display
restricted developmental and proliferative capacities. Neuron 15:527–539.
17. Metzger M (2010) Neurogenesis in the enteric nervous system. Arch Ital Biol 148:
73–83.
18. Metzger M, et al. (2009) Expansion and differentiation of neural progenitors
derived from the human adult enteric nervous system. Gastroenterology 137:
2063–2073 e2064.
19. Metzger M, Caldwell C, Barlow AJ, Burns AJ, Thapar N (2009) Enteric nervous system
stem cells derived from human gut mucosa for the treatment of aganglionic gut
disorders. Gastroenterology 136:2214–2225.e1-3.
20. Natarajan D, Grigoriou M, Marcos-Gutierrez CV, Atkins C, Pachnis V (1999) Multipo-
tential progenitors of the mammalian enteric nervous system capable of colonising
aganglionic bowel in organ culture. Development 126:157–168.
21. Rauch U, Hänsgen A, Hagl C, Holland-Cunz S, Schäfer KH (2006) Isolation and culti-
vation of neuronal precursor cells from the developing human enteric nervous system
as a tool for cell therapy in dysganglionosis. Int J Colorectal Dis 21:554–559.
22. Suárez-Rodríguez R, Belkind-Gerson J (2004) Cultured nestin-positive cells from
postnatal mouse small bowel differentiate ex vivo into neurons, glia, and smooth
muscle. Stem Cells 22:1373–1385.
23. Schäfer KH, Hagl CI, Rauch U (2003) Differentiation of neurospheres from the enteric
nervous system. Pediatr Surg Int 19:340–344.
24. Puig I, et al. (2009) Deletion of Pten in the mouse enteric nervous system induces
ganglioneuromatosis and mimics intestinal pseudoobstruction. J Clin Invest 119:
3586–3596.
25. Sanno H, et al. (2010) Control of postnatal apoptosis in the neocortex by RhoA-
subfamily GTPases determines neuronal density. J Neurosci 30:4221–4231.
26. Nezami BG, et al. (2014) MicroRNA 375 mediates palmitate-induced enteric neuronal
damage and high-fat diet-induced delayed intestinal transit in mice. Gastroenterology
146:473–483 e473.
27. Becker L, et al. (2017) Age-dependent shift in macrophage polarisation causes
inflammation-mediated degeneration of enteric nervous system. Gut, 10.1136/gutjnl-
2016-312940.
28. Hristov G, et al. (2014) SHOX triggers the lysosomal pathway of apoptosis via oxi-
dative stress. Hum Mol Genet 23:1619–1630.
29. Hussain ST, Attilo A, Bigotte L, Cesarini K, Olsson Y (1985) Cytofluorescence locali-
zation of propidium iodide injected intravenously into the nervous system of the
mouse. Acta Neuropathol 66:62–67.
30. Unal Cevik I, Dalkara T (2003) Intravenously administered propidium iodide labels
necrotic cells in the intact mouse brain after injury. Cell Death Differ 10:928–929.
31. Brana C, Benham C, Sundstrom L (2002) A method for characterising cell death in vitro
by combining propidium iodide staining with immunohistochemistry. Brain Res Brain
Res Protoc 10:109–114.
32. Rakhilin N, et al. (2016) Simultaneous optical and electrical in vivo analysis of the
enteric nervous system. Nat Commun 7:11800.
33. Margolis KG, Gershon MD, Bogunovic M (2016) Cellular organization of neuro-
immune interactions in the gastrointestinal tract. Trends Immunol 37:487–501.
34. Muller PA, et al. (2014) Crosstalk between muscularis macrophages and enteric
neurons regulates gastrointestinal motility. Cell 158:300–313.
35. Gautron L, et al. (2013) Neuronal and nonneuronal cholinergic structures in the
mouse gastrointestinal tract and spleen. J Comp Neurol 521:3741–3767.
36. Heng TS, Painter MW; Immunological Genome Project Consortium (2008) The Im-
munological Genome Project: Networks of gene expression in immune cells. Nat
Immunol 9:1091–1094.
37. Steinert PM, et al. (1999) A high molecular weight intermediate filament-associated
protein in BHK-21 cells is Nestin, a type VI intermediate filament protein. Limited co-
assembly in vitro to form heteropolymers with type III vimentin and type IV alpha-
internexin. J Biol Chem 274:9881–9890.
38. Mignone JL, et al. (2007) Neural potential of a stem cell population in the hair follicle.
Cell Cycle 6:2161–2170.
39. Mignone JL, Kukekov V, Chiang AS, Steindler D, Enikolopov G (2004) Neural stem and
progenitor cells in nestin-GFP transgenic mice. J Comp Neurol 469:311–324.
40. Becker L, Peterson J, Kulkarni S, Pasricha PJ (2013) Ex vivo neurogenesis within enteric
ganglia occurs in a PTEN dependent manner. PLoS One 8:e59452.
41. Birbrair A, Wang ZM, Messi ML, Enikolopov GN, Delbono O (2011) Nestin-GFP
transgene reveals neural precursor cells in adult skeletal muscle. PLoS One 6:e16816.
42. Bonaguidi MA, et al. (2011) In vivo clonal analysis reveals self-renewing and multi-
potent adult neural stem cell characteristics. Cell 145:1142–1155.
43. Fu YY, Peng SJ, Lin HY, Pasricha PJ, Tang SC (2013) 3-D imaging and illustration of
mouse intestinal neurovascular complex. Am J Physiol Gastrointest Liver Physiol 304:
G1–G11.
44. Corpening JC, et al. (2011) Isolation and live imaging of enteric progenitors based on
Sox10-Histone2BVenus transgene expression. Genesis 49:599–618.
45. Uesaka T, Nagashimada M, Enomoto H (2015) Neuronal differentiation in Schwann
cell lineage underlies postnatal neurogenesis in the enteric nervous system. J Neurosci
35:9879–9888.
46. Wilm B, Ipenberg A, Hastie ND, Burch JB, Bader DM (2005) The serosal mesothelium is
a major source of smooth muscle cells of the gut vasculature. Development 132:
5317–5328.
47. Shimada A, Shibata T, Komatsu K, Nifuji A (2008) Improved methods for immuno-
histochemical detection of BrdU in hard tissue. J Immunol Methods 339:11–16.
48. Kimoto M, Yura Y, Kishino M, Toyosawa S, Ogawa Y (2008) Label-retaining cells in the
rat submandibular gland. J Histochem Cytochem 56:15–24.
49. Boesmans W, Lasrado R, Vanden Berghe P, Pachnis V (2015) Heterogeneity and
phenotypic plasticity of glial cells in the mammalian enteric nervous system. Glia 63:
229–241.
50. Rao M, et al. (2015) Enteric glia express proteolipid protein 1 and are a transcrip-
tionally unique population of glia in the mammalian nervous system. Glia 63:
2040–2057.
51. Azan G, Low WC, Wendelschafer-Crabb G, Ikramuddin S, Kennedy WR (2011) Evi-
dence for neural progenitor cells in the human adult enteric nervous system. Cell
Tissue Res 344:217–225.
52. Lindley RM, et al. (2008) Human and mouse enteric nervous system neurosphere trans-
plants regulate the function of aganglionic embryonic distal colon. Gastroenterology
135:205–216.e6.
53. Hotta R, et al. (2013) Transplanted progenitors generate functional enteric neurons in
the postnatal colon. J Clin Invest 123:1182–1191.
54. Belkind-Gerson J, et al. (2015) Colitis induces enteric neurogenesis through a 5-HT4-
dependent mechanism. Inflamm Bowel Dis 21:870–878.
55. Cook RD, Burnstock G (1976) The altrastructure of Auerbach’s plexus in the guinea-
pig. I. Neuronal elements. J Neurocytol 5:171–194.
56. Anitha M, et al. (2006) GDNF rescues hyperglycemia-induced diabetic enteric neu-
ropathy through activation of the PI3K/Akt pathway. J Clin Invest 116:344–356.
57. Gianino S, Grider JR, Cresswell J, Enomoto H, Heuckeroth RO (2003) GDNF availability
determines enteric neuron number by controlling precursor proliferation. Development
130:2187–2198.
58. Stenkamp-Strahm CM, Kappmeyer AJ, Schmalz JT, Gericke M, Balemba O (2013) High-
fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of
obese mice with symptoms of type 2 diabetes. Cell Tissue Res 354:381–394.
59. Kristiansen M, Ham J (2014) Programmed cell death during neuronal development:
The sympathetic neuron model. Cell Death Differ 21:1025–1035.
60. Gershon MD (2011) Behind an enteric neuron there may lie a glial cell. J Clin Invest
121:3386–3389.
61. Taylor CR, Montagne WA, Eisen JS, Ganz J (2016) Molecular fingerprinting delineates
progenitor populations in the developing zebrafish enteric nervous system. Dev Dyn
245:1081–1096.
62. Bai X, et al. (2013) Genetic background affects human glial fibrillary acidic protein
promoter activity. PLoS One 8:e66873.
63. Mandyam CD, Harburg GC, Eisch AJ (2007) Determination of key aspects of precursor
cell proliferation, cell cycle length and kinetics in the adult mouse subgranular zone.
Neuroscience 146:108–122.
64. Gabella G (1989) Fall in the number of myenteric neurons in aging guinea pigs.
Gastroenterology 96:1487–1493.
65. Garcia SB, et al. (2002) No reduction with ageing of the number of myenteric neurons
in benzalkonium chloride treated rats. Neurosci Lett 331:66–68.
66. Spencer NJ (2016) Motility patterns in mouse colon: Gastrointestinal dysfunction in-
duced by anticancer chemotherapy. Neurogastroenterol Motil 28:1759–1764.
67. Ro S, Hwang SJ, Muto M, Jewett WK, Spencer NJ (2006) Anatomic modifications in the
enteric nervous system of piebald mice and physiological consequences to colonic
motor activity. Am J Physiol Gastrointest Liver Physiol 290:G710–G718.
68. Kabouridis PS, et al. (2015) Microbiota controls the homeostasis of glial cells in the gut
lamina propria. Neuron 85:289–295.
69. Crosnier C, Stamataki D, Lewis J (2006) Organizing cell renewal in the intestine: Stem
cells, signals and combinatorial control. Nat Rev Genet 7:349–359.
70. McQuade RM, et al. (2016) Gastrointestinal dysfunction and enteric neurotoxic-
ity following treatment with anticancer chemotherapeutic agent 5-fluorouracil.
Neurogastroenterol Motil 28:1861–1875.
71. Soares A, Beraldi EJ, Ferreira PE, Bazotte RB, Buttow NC (2015) Intestinal and neu-
ronal myenteric adaptations in the small intestine induced by a high-fat diet in mice.
BMC Gastroenterol 15:3.
72. Molofsky AV, et al. (2006) Increasing p16INK4a expression decreases forebrain pro-
genitors and neurogenesis during ageing. Nature 443:448–452.
73. Gown AM, Willingham MC (2002) Improved detection of apoptotic cells in archival
paraffin sections: Immunohistochemistry using antibodies to cleaved caspase 3.
J Histochem Cytochem 50:449–454.
74. Shirasawa S, et al. (1997) Enx (Hox11L1)-deficient mice develop myenteric neuronal
hyperplasia and megacolon. Nat Med 3:646–650.
75. Kuo YM, et al. (2010) Extensive enteric nervous system abnormalities in mice trans-
genic for artificial chromosomes containing Parkinson disease-associated alpha-
synuclein gene mutations precede central nervous system changes. Hum Mol Genet
19:1633–1650.
E3718 | www.pnas.org/cgi/doi/10.1073/pnas.1619406114 Kulkarni et al.
